Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Efficacy and Toxicity of FLAG-IDA-Venetoclax Compared With Other Induction Regimens in Newly Diagnosed and Relapsed AML: A Real-World Single-Center Study

AML - 132

Efficacy and Toxicity of FLAG-IDA-Venetoclax Compared With Other Induction Regimens in Newly Diagnosed and Relapsed AML: A Real-World Single-Center Study

Rita Ahmad

Poster Presenter: Rita Ahmad

Thumbnail for Melatonin Enhances Venetoclax Sensitivity Through Modulation of Apoptotic and Resistance Pathways in Acute Myeloid Leukemia

AML - 1321

Melatonin Enhances Venetoclax Sensitivity Through Modulation of Apoptotic and Resistance Pathways in Acute Myeloid Leukemia

Joao Agostinho Machado-Neto

Poster Presenter: Joao Agostinho Machado-Neto

Previous 1...25 26 27 28 29 30 31...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

$Thumbnail for Efficacy and Safety of Triplet Targeted Therapy for FLT3-Mutated Relapsed/Refractory AML: A Systematic Review and Proportion Meta-Analysis$

AML - 1336

Efficacy and Safety of Triplet Targeted Therapy for FLT3-Mutated Relapsed/Refractory AML: A Systematic Review and Proportion Meta-Analysis

Mehak Dang

Poster Presenter: Mehak Dang

Thumbnail for MRD-Guided Risk Stratification in Venetoclax-Treated Newly Diagnosed AML: A Pooled Survival Analysis

AML - 1351

MRD-Guided Risk Stratification in Venetoclax-Treated Newly Diagnosed AML: A Pooled Survival Analysis

Nuri Tamanna

Poster Presenter: Nuri Tamanna

Thumbnail for Risk Stratification of Patients Treated for NPM1 Mutated Acute Myeloid Leukemia: A Single Center Retrospective Study.

AML - 1354

Risk Stratification of Patients Treated for NPM1 Mutated Acute Myeloid Leukemia: A Single Center Retrospective Study.

Mohammed Almakadi

Poster Presenter: Mohammed Almakadi

Thumbnail for Outcomes of Complex Karyotype Acute Myeloid Leukemia Stratified by TP53 Mutation Status and Treatment Intensity: A Single-Institution Retrospective Analysis

AML - 1356

Outcomes of Complex Karyotype Acute Myeloid Leukemia Stratified by TP53 Mutation Status and Treatment Intensity: A Single-Institution Retrospective Analysis

Andy Li

Poster Presenter: Andy Li

Thumbnail for Global, Regional, and National Macroeconomic Burden of Acute Myeloid Leukemia: A Value-of-Lost-Welfare Analysis of 184 Countries, 2023

AML - 1359

Global, Regional, and National Macroeconomic Burden of Acute Myeloid Leukemia: A Value-of-Lost-Welfare Analysis of 184 Countries, 2023

Sai Varun Gadde

Poster Presenter: Sai Varun Gadde

Thumbnail for Epigenetic Gene Expression Profiling as a Predictor of Ex Vivo Venetoclax Sensitivity in Acute Myeloid Leukemia

AML - 1373

Epigenetic Gene Expression Profiling as a Predictor of Ex Vivo Venetoclax Sensitivity in Acute Myeloid Leukemia

Pranav Singh

Poster Presenter: Pranav Singh

Thumbnail for Comparative Effectiveness of Standard 3+7 Versus FLAG/FLAG-IDA Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia: A Propensity Score-Matched Cohort Study Using the TriNetX Global Network

AML - 138

Comparative Effectiveness of Standard 3+7 Versus FLAG/FLAG-IDA Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia: A Propensity Score-Matched Cohort Study Using the TriNetX Global Network

Rita Ahmad

Poster Presenter: Rita Ahmad

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors